NCT05447234View on ClinicalTrials.gov

TCRx_T Cells for Advanced or Recurrent Gastric/Gastroesophageal Junction Cancer After Failure of First Chemotherapy

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

March 1, 2026

Study Completion Date

March 1, 2028

Conditions
Gastric CancerGastroesophageal-junction Cancer
Interventions
BIOLOGICAL

Tcrx T cell

Sequential IV infusion

All Listed Sponsors
collaborator

TCRx Therapeutics Co.Ltd

INDUSTRY

lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

NCT05447234 - TCRx_T Cells for Advanced or Recurrent Gastric/Gastroesophageal Junction Cancer After Failure of First Chemotherapy | Biotech Hunter | Biotech Hunter